-
公开(公告)号:US06368625B1
公开(公告)日:2002-04-09
申请号:US09372738
申请日:1999-08-11
IPC分类号: A61K920
CPC分类号: A61K9/0007 , A61K9/0056 , A61K9/2009 , A61K9/2054 , A61K9/2081 , A61K9/5042 , A61K9/5047
摘要: A dosage form which rapidly disintegrates in the mouth and forms a viscous slurry of either microcapsules or a powder is described. The rapidly disintegrating dosage form is meant for direct oral administration by placing a tablet or capsule in the mouth of a patient. Upon disintegration, a viscosity of the resulting slurry increases so as to form an organoleptically pleasant viscous material which retards the spread of insoluble materials including the drug.
摘要翻译: 描述了在口中快速崩解并形成微胶囊或粉末的粘性浆液的剂型。 快速崩解的剂型意在通过将片剂或胶囊置于患者的口中直接口服给药。 在分解时,所得浆料的粘度增加,以形成感官愉悦的粘稠材料,其阻止包括药物在内的不溶物质的铺展。
-
公开(公告)号:US07670617B2
公开(公告)日:2010-03-02
申请号:US10936185
申请日:2004-09-08
申请人: S. Indiran Pather , John Hontz , John M. Siebert
发明人: S. Indiran Pather , John Hontz , John M. Siebert
IPC分类号: A61F9/02
CPC分类号: A61K9/0034 , A61K9/025 , A61K9/2054 , A61K9/2081 , A61K31/48
摘要: The invention relates to methods and composition for improving absorption and dissolution of active ingredients of drugs. The invention provides a method of administration of an active ingredient to a mammal through a transmucosal route that includes delivering the active ingredient to a desired site in a body of the mammal, and, sequentially, at the desired site, promoting dissolution and absorption of the active ingredient. In a preferred embodiment, the pH of the localized environment of the active ingredient is sequentially modified to promote dissolution and absorption.
摘要翻译: 本发明涉及用于改善药物活性成分吸收和溶解的方法和组合物。 本发明提供了通过经粘膜途径向哺乳动物施用活性成分的方法,其包括将活性成分递送至哺乳动物体内的期望部位,并且依次在所需位点促进溶解和吸收 有效成分。 在优选的实施方案中,活性成分的局部环境的pH被依次修饰以促进溶解和吸收。
-
3.
公开(公告)号:US20090312724A1
公开(公告)日:2009-12-17
申请号:US12479576
申请日:2009-06-05
CPC分类号: A61M31/00 , A61K9/0043 , A61K9/0048 , A61K9/08 , A61K31/335 , A61K31/506 , A61K31/55 , A61K31/56 , A61K31/57 , A61K31/58 , A61K31/724 , A61K45/06 , A61K47/40 , A61K2300/00
摘要: The present invention is directed to methods of treating nasal and/or ophthalmic diseases, symptoms, or disorders that are therapeutically responsive to corticosteroid therapy by delivering aqueous solution formulations comprising a corticosteroid to nasal and ophthalmic tissues. The invention is also directed to methods, systems, devices, and compositions for delivering aqueous solution formulations comprising a corticosteroid and an antihistamine to nasal and ophthalmic tissues.
摘要翻译: 本发明涉及通过将包含皮质类固醇的水溶液制剂递送至鼻和眼组织来治疗对皮质类固醇治疗有治疗反应的鼻和/或眼部疾病,症状或病症的方法。 本发明还涉及用于将包含皮质类固醇和抗组胺药物的水溶液制剂递送至鼻和眼组织的方法,系统,装置和组合物。
-
-